Chief Operating Officer
Michael Brooks is Chief Operating Officer of Syneos Health where he oversees operations and realizing strategy execution across the clinical to commercial continuum. He has more than 25 years of clinical development and commercialization experience, a strong track record of creating greater customer success through integrated solutions and technology-driven insights, and a passion for helping colleagues across the globe achieve their career goals.
Prior to joining Syneos Health in 2021, Michael served as President & Global Head of LabCorp (Covance) Clinical Development & Commercialization Services, where he was responsible for phase I-IV services, FSPx services, clinical pharmacology/phase I units, global service delivery hubs in China and India, and commercial services. He also previously worked for PRA Health Sciences and PPD.
Michael holds a B.S. from North Carolina State University and is currently a member of the NCSU College of Sciences Foundation Board of Directors.